ClinicalTrials.Veeva

Menu

Development of a New Neuroimaging Method Aimed to Differentiate Mnesic Abilities of Alzheimer and Depressed Patients (RIHANNA)

C

Centre Hospitalier Universitaire de Besancon

Status

Unknown

Conditions

Alzheimer Disease
Depression

Treatments

Device: high-density electroencephalography

Study type

Interventional

Funder types

Other

Identifiers

NCT02840045
API/2014/51

Details and patient eligibility

About

The purpose of this study is to use a new method to differentiate mnesic abilities of early alzheimer patients and patients with a depressive disorder.

This method is based on the recording of cerebral activity while patients listen to familiar, unfamiliar and newly-learned music.

Enrollment

30 estimated patients

Sex

All

Ages

60+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Being right-handed
  • recorded consent
  • For Alzheimer patients: Mini Mental Status Examination (MMSE) score >= 18
  • For patients with a depressive disorder : Major Depressive Disorder according to Diagnostic and Statistical Manual of Mental Disorders (DSM IV) and Montgomery-Asberg depression rating scale (MADRS) score >= 25
  • For healthy controls : no cognitive deficit, MADRS score < 25, no depressive disorder according to DSM IV

Exclusion criteria

  • Auditory deficit
  • contraindication to a high-density electroencephalography exam
  • refusal to participate in the study

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

30 participants in 3 patient groups

Alzheimer patients
Experimental group
Description:
Cerebral measurements from high-density electroencephalography are recorded in Alzheimer patients. The same protocol is applied in the 3 arms
Treatment:
Device: high-density electroencephalography
patients with a depressive disorder
Experimental group
Description:
Cerebral measurements from high-density electroencephalography are recorded in patients with a depressive disorder. The same protocol is applied in the 3 arms
Treatment:
Device: high-density electroencephalography
Healthy controls
Active Comparator group
Description:
Cerebral measurements from high-density electroencephalography are recorded in healthy controls
Treatment:
Device: high-density electroencephalography

Trial contacts and locations

1

Loading...

Central trial contact

Damien Gabriel, PhD; Magali Nicolier, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems